Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fang, San Diego

Changming Fang, San Diego, CA US

Patent application numberDescriptionPublished
20090074785Compositions and methods for treatment of colorectal cancer - We have identified a new variant of ileal bile acid binding protein (IBABP), designated IBABP-L, which is a biomarker for colorectal cancer. The transcript for IBABP-L arises from an alternative start site and includes three exons that are absent in IBABP. IBABP-L also shares part of a fourth exon with IBABP. The protein encoded by IBABP-L contains a deduced 49 residue N-terminal sequence that is not found in the IBABP protein. The present invention provides, for example, compositions and methods for diagnosing and treating colorectal cancer.03-19-2009

Douglas Dong Fang, San Diego, CA US

Patent application numberDescriptionPublished
20090130065Multipotent adult stem cells - Isolated human multipotent adult stem cell and isolated populations of cells that include human multipotent adult stem cells are disclosed. Human hair-follicle derived multipotent adult stem cells and methods of preparing isolated populations of cells that include human multipotent adult stem cells are disclosed. Isolated human hair-follicle derived multipotent adult stem cell that can differentiate in culture into a neuronal cell, a glial cell, a melanocyte cell, a muscle cell, an osteocyte, a chondrocyte, and a lymphocyte. Isolated human hair-follicle derived multipotent adult stem cell that can grow in cell culture in spheres are disclosed. Human pancreas derived multipotent adult stem cells, human liver derived multipotent adult stem cells, human kidney derived multipotent adult stem cells, human heart derived multipotent adult stem cells, human neural derived multipotent adult stem cells and methods of preparing isolated populations of cells that include such human multipotent adult stem cells are disclosed. Method of treating an individual who has diabetes, cardiac muscle damage, muscle damage and disease, neurodegenerative disease or nerve damage or injury, bone loss, damage and/or disease, cartilage loss, damage and/or disease, hair loss and immune disorders, are disclosed.05-21-2009

Fang Fang, San Diego, CA US

Patent application numberDescriptionPublished
20080299121Multivalent recombinant antibodies for treating HRV infections - The present invention relates to high affinity multivalent recombinant antibodies and multivalent peptides against ICAM-1 and/or LDL receptor and pharmaceutical compositions containing such multivalent antibodies or multivalent peptides. The present invention also relates to methods of using such multivalent antibodies or multivalent peptides to prevent and treat human rhinovirus infection and diseases and pathological conditions associated therewith.12-04-2008
20090098207Technology for the Preparation of Microparticles - Microspheres are produced by contacting a solution of a macromolecule or small molecule in a solvent with an antisolvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals, nutraceuticals, cosmetic products and the like of defined dimensions.04-16-2009
20090142327Novel Class of Therapeutic Protein Based Molecules - The present invention provides new compositions and methods for preventing and treating pathogen infection. In particular, the present invention provides compounds having an anchoring domain that anchors the compound to the surface of a target cell, and a therapeutic domain that can act extracellularly to prevent infection of a target cell by a pathogen, such as a virus. The present invention also comprises therapeutic compositions having sialidase activity, including protein-based compounds having sialidase catalytic domains. Compounds of the invention can be used for treating or preventing pathogen infection, and for treating and reducing allergic and inflammatory responses. The invention also provides compositions and methods for enhancing transduction of target cells by recombinant viruses. Such compositions and methods can be used in gene therapy.06-04-2009
20100166874Technology for Preparation of Macromolecular Microspheres - Microspheres are produced by contacting an aqueous solution of a protein or other macromolecule with an organic solvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals of defined dimensions.07-01-2010
20110044976HUMANIZED ANTIBODIES - Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.02-24-2011

Patent applications by Fang Fang, San Diego, CA US

Su-Chiung Fang, San Diego, CA US

Patent application numberDescriptionPublished
20090280545MOLECULE PRODUCTION BY PHOTOSYNTHETIC ORGANISMS - The present invention provides compositions and methods for producing products by photosynthetic organisms. The photosynthetic organisms are genetically modified to effect production, secretion, or both, of products. The methods and compositions are particularly useful in the petrochemical industry.11-12-2009

Taiyuan Fang, San Diego, CA US

Patent application numberDescriptionPublished
20090265175Method and system for providing a translation service for a voice channel - There is provided a method for providing a translation service for a voice channel. The method comprises receiving a translation request from a first person at a first endpoint of the voice channel, selecting a language translator based on the translation request received from the first person, and installing the language translator in the voice channel for providing the translation service between the first person at the first endpoint of the voice channel and a second person at a second endpoint of the voice channel. The translation request may include digits dialed as part of a phone number associated with the second endpoint, and wherein the translation request includes information indicative of a first language and a second language for translation.10-22-2009
20090320144Method and system for transferring protected content - There is provided a method of transferring a protected content, in which the method comprises receiving from a first player the protected content via a transmission medium calculating usage rights associated with the protected content to confirm receipt from the first player of some or all of the usage rights associated with the protected content making available the protected content for distribution to a second player, and transmitting the protected content to the second player. The method also includes confirming that the first player has relinquished the some or all of the usage rights associated with the protected content prior to transmitting the protected content to the second player. The protected content may comprise a music file, and the some or all of the usage rights may comprise a usage right for a limited number of protected content players, or comprise a usage right for a limited time duration.12-24-2009

Xue Fang, San Diego, CA US

Patent application numberDescriptionPublished
20090110066Method and Apparatus for Selecting a Coding Mode - A method and apparatus for selecting a coding mode for a block of a current picture are disclosed. For example, the method selects a coding mode in accordance with a cost function, for coding the block, wherein the cost function comprises a coding distortion parameter and a number of coding bits parameter, wherein said coding distortion parameter is measured in accordance with at least one of: between a prediction residual and a reconstructed prediction residual, or between a transformed prediction residual and a dequantized transformed prediction residual, wherein the number of coding bits parameter is computed in accordance with at least one of: from a true number of compressed bits resulting from coding said block, directly from a plurality of bins, or directly from a plurality of quantized transform coefficients.04-30-2009
20090161697Method and System for Interleaving Video and Data for Transmission over a Network at a Selected Bit Rate - A StatMux system and method are provided for efficiently allocating time slots on the transmission channel between bit streams representing video and bit streams representing data. By providing such a system and method, when a decreased number of data bits need to be transmitted, a decreased number of time slots may be allocated for transmitting the data bits and an increased number of time slots may be allocated for transmitting video bits. When a decreased number of video bits needs to be transmitted, a decreased number of time slots may be allocated for transmitting video bits and an increased number of time slots may be allocated for transmitting data bits.06-25-2009
20100158120Reference Picture Selection for Sub-Pixel Motion Estimation - A video coding system includes a prediction module configured to perform multi-reference picture sub-pixel motion estimation. Reference pictures are selected for the sub-pixel motion estimation based on full-pixel motion estimation. A cost function is used to select the reference pictures from one or more groups of reference pictures for a block in a macroblock. The cost is based on full-pixel motion estimation errors and a predicted motion vector for the block. The selected reference pictures are used for sub-pixel motion estimation to get the final motion vector for each block.06-24-2010

Patent applications by Xue Fang, San Diego, CA US

Yungeng Fang, San Diego, CA US

Patent application numberDescriptionPublished
20100234404P-38 Kinase Inhibitors - Compounds and compositions for modulating the activity of p38 kinases are provided, including p38α, and p38β kinase. Methods for treating, preventing or ameliorating one or more symptoms of a p38 kinase mediated disease or disorder are also provided.09-16-2010

Zheng Fang, San Diego, CA US